Last Price
71.08
Today's Change
+1.87 (2.70%)
Day's Change
70.36 - 71.70
Trading Volume
1,449,969
Market Cap
13 Billion
Shares Outstanding
184 Million
Avg Volume
2,882,552
Avg Price (50 Days)
56.00
Avg Price (200 Days)
58.80
PE Ratio
-74.92
EPS
-0.95
Earnings Announcement
30-Oct-2024
Previous Close
69.21
Open
70.98
Day's Range
70.36 - 71.7
Year Range
40.62 - 79.62
Trading Volume
1,451,566
1 Day Change
5 Day Change
1 Month Change
3 Month Change
6 Month Change
Ytd Change
1 Year Change
3 Year Change
5 Year Change
10 Year Change
Max Change
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.